Medicare Enrolled
Dr. Bramham Reddy, M.D.
Hematology & Oncology · Lufkin, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Bramham Reddy is a hematology & oncology specialist in Lufkin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 40,453 Medicare services across 1,877 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $68,975 from 47 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in TX
$68,975 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,453
Medicare services
Top 24% in TX for hematology & oncology
1,877
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,129 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
14,300 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
12,170 | $6 | $45 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,705 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,612 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,252 | $8 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,225 | $8 | $65 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,190 | $1 | $52 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
636 | $92 | $849 |
| High osmolar contrast material, 350-399 mg/ml iodine A radiographic contrast agent with a high iodine concentration used to enhance imaging studies. It is measured and billed per milliliter administered. |
600 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
588 | $95 | $350 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
454 | $11 | $65 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
329 | $12 | $80 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
273 | $22 | $205 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
272 | $101 | $550 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
206 | $59 | $145 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
198 | $42 | $85 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
198 | $7 | $276 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
190 | $49 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $59 | $249 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
104 | $22 | $225 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
99 | $50 | $275 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
82 | $1 | $14 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
77 | $18 | $250 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
49 | $26 | $130 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
47 | $5 | $10 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
47 | $3 | $10 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
46 | $1,192 | $7,154 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
45 | $1 | $48 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
43 | $91 | $1,135 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
43 | $216 | $1,800 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 42 | $127 | $650 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $137 | $450 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $122 | $475 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
28 | $1 | $20 |
| New patient office visit, complex (60-74 min) | 24 | $167 | $495 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
21 | $10 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
86.5% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$68,975
Total received (2018-2024)
Avg $9,854/year across 7 years
Top 9% in TX for hematology & oncology
47
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$51,487 (74.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,865 (21.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,623 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,191
2023
$3,693
2022
$11,751
2021
$15,295
2020
$1,459
2019
$12,201
2018
$9,386
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$17,599
AstraZeneca Pharmaceuticals LP
$11,463
CTI BioPharma Corp.
$5,750
Coherus Biosciences Inc.
$5,443
Takeda Pharmaceuticals U.S.A., Inc.
$4,541
Karyopharm Therapeutics Inc.
$4,450
Exelixis Inc.
$3,370
Pharmacosmos Therapeutics Inc.
$3,201
Janssen Biotech, Inc.
$2,113
Genentech USA, Inc.
$1,578
MorphoSys, US Inc.
$1,440
Athenex Pharmaceutical Division, LLC
$1,200
Daiichi Sankyo Inc.
$1,170
Seattle Genetics, Inc.
$924
BeiGene USA, Inc.
$699
Astellas Pharma US Inc
$633
SANOFI-AVENTIS U.S. LLC
$350
Amgen Inc.
$290
E.R. Squibb & Sons, L.L.C.
$286
Pharmacyclics LLC, An AbbVie Company
$242
Celgene Corporation
$204
Seagen Inc.
$203
SOBI, INC
$200
GlaxoSmithKline, LLC.
$159
ABBVIE INC.
$131
Ipsen Biopharmaceuticals, Inc
$119
GENZYME CORPORATION
$107
Merck Sharp & Dohme LLC
$100
Alexion Pharmaceuticals, Inc.
$99
Gilead Sciences, Inc.
$96
Kite Pharma, Inc.
$94
PFIZER INC.
$88
Lilly USA, LLC
$86
Novartis Pharmaceuticals Corporation
$85
Janssen Scientific Affairs, LLC
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Regeneron Healthcare Solutions, Inc.
$65
Tempus AI, Inc
$49
Stemline Therapeutics Inc.
$33
Sun Pharmaceutical Industries Inc.
$29
Celltrion USA Inc.
$28
JAZZ PHARMACEUTICALS INC.
$27
Deciphera Pharmaceuticals Inc.
$24
Genmab U.S., Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Pharmacyclics LLC, an AbbVie Company
$15
Acrotech Biopharma LLC
$12
Top 3 companies account for 50.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · BELEODAQ · BLENREP · BRUKINSA · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · EMPLICITI · EPKINLY · Enhertu · Epkinly · Erleada · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · MONJUVI · MONOFERRIC · NINLARO · OJJAARA · OPDIVO · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · Paclitaxel · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SOLIRIS · Stivarga · TAGRISSO · TECENTRIQ · Trodelvy · Udenyca · VEGZELMA · VELCADE · VENCLEXTA · VONJO · Vonjo · XOSPATA · XPOVIO · XT CDX · XTANDI · Xtandi · Yescarta · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for hematology & oncology in TX.
Equivalent to $171 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
3
Per 100K population
3.5
County median income
$58,847
Nearest hospital
WOODLAND HEIGHTS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 24% in TX), with consulting-driven industry engagement in the top 9% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Reddy performed 14,300 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $68,975 from 47 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other hematology & oncology specialists in Lufkin?
Dr. Reddy's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lufkin
Browse hematology & oncology specialists in Lufkin ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
CTI BioPharma Corp. Payments to Doctors
See all physicians who received payments from CTI BioPharma Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology